Retaining Short-term Training Effects on Gait Adaptability in People With Stroke
Launched by SINT MAARTENSKLINIEK · Apr 11, 2023
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to help people who have had a stroke improve their walking abilities, specifically by focusing on adapting their gait (the way they walk) to different environments. Many stroke survivors regain the ability to walk, but often struggle to adjust their walking to different situations, which can affect their daily lives. The trial will examine if short training sessions or home exercises can help maintain the improvements made during a 5-week training program designed to enhance gait adaptability.
To participate in this study, you should be at least 6 months post-stroke, able to walk independently for at least 10 minutes, and have completed the initial 5-week training program. The study will involve around 50 to 75 participants who will be randomly assigned to different groups: some will receive additional training sessions, others will do home exercises, and some will not receive any further intervention. The goal is to see which method helps keep the benefits of the original training lasting for a year. If you join, you can expect to contribute to important research that could help improve rehabilitation for stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \> 6 months after first unilateral supratentorial stroke (chronic phase)
- • Able to walk at least 10 minutes independently
- • Initial involvement of the lower extremity after stroke.
- • Having completed (minimal 8/10 training sessions) the 5 week gait adaptability training program using the C-Mill
- Exclusion Criteria:
- • Any other neurological or musculoskeletal disease affecting gait or balance (e.g. Parkinson's disease, knee osteoarthritis)
- • Contractures or spasticity requiring other treatment (e.g. botulinum toxin treatment) within the duration of the training period.
- • Severe cognitive or visuo-spatial impairments limiting comprehension of instructions or correct perception of the environments
About Sint Maartenskliniek
Sint Maartenskliniek is a leading Dutch specialized hospital renowned for its expertise in orthopedics, rehabilitation, and chronic pain management. With a strong commitment to advancing medical research and improving patient outcomes, the institution actively conducts clinical trials that focus on innovative treatments and therapies. Sint Maartenskliniek collaborates with various stakeholders, including academic institutions and industry partners, to foster an environment of rigorous scientific inquiry and to translate research findings into clinical practice. Through its dedication to excellence in patient care and research, Sint Maartenskliniek aims to enhance the quality of life for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ubbergen, , Netherlands
Patients applied
Trial Officials
Vivian Weerdesteyn, Prof. dr.
Principal Investigator
Sint Maartenskliniek
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported